What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the price band for Global Health Limited IPO?

The price band for Global Health Limited IPO is set at ₹336 to ₹336 per equity share with a minimum lot size of 44 shares.

When does Global Health Limited IPO open and close?

The Global Health Limited IPO opens on 2022-11-03 and closes on 2022-11-07. The allotment date is 2022-11-11 and the listing date is 2022-11-16.

What is the current GMP of Global Health Limited IPO?

The current grey market premium (GMP) for Global Health Limited IPO is ₹33, implying an estimated listing price of ₹369 (9.82% gain over the upper price band).

How do I check Global Health Limited IPO allotment status?

You can check the allotment status on the registrar's official portal (Kfin Technologies Limited) or through the BSE/NSE allotment websites once the basis of allotment is finalized.

Global Health Limited

ListedMainboard

Healthcare · NSE / BSE

Global Health Limited is one of the largest private multi-speciality tertiary care providers in North and East India, operating under the "Medanta" brand. The company specializes in cardiology, neurosciences, oncology, digestive sciences, orthopaedics, liver transplants, and kidney care. With hospitals in Gurugram, Indore, Ranchi, and Lucknow, it offers healthcare services across 30 medical specialities with over 1,300 doctors and 2,467 installed beds. Medanta’s Gurugram hospital was ranked India’s best private hospital from 2020 to 2022 and featured in Newsweek’s global hospital rankings. The company emphasizes clinical research, academic excellence, and advanced medical infrastructure. Its strong financial performance, presence in high-demand areas, and expansion into digital health contribute to its growth. Backed by experienced management and institutional investors, Global Health Limited continues to strengthen its position in India's healthcare sector.

Price Band

₹336

Issue Size

₹2206 Cr

Lot Size

44 shares

GMP

₹33

+9.8%

Est. Listing

₹369

at current GMP

Subscribed

9.58x

overall

Open

3 Nov 2022

7 Nov 2022

Allotment

11 Nov 2022

Refund

12 Nov 2022

Demat Credit

13 Nov 2022

Listing

16 Nov 2022

Last updated 12 days ago

Overview GMP Subscription Financials IPO Details Company Promoters Objects Peers Documents Allotment FAQs

Key Highlights

•Leading player in the Healthcare segment
•Price band established at ₹336 - ₹336 per equity share
•Minimum bid lot is 44 shares
•Estimated listing target of ₹369 based on current grey market activity